Table 3 Factors associated with poor anticoagulation and other secondary outcomes in long term care in Africa
Authors’ name | Factors associated with poor anticoagulation outcomes (low TTR%) | Factors associated with bleeding events | Factors associated with Thromboembolism events | Factors associated with hospitalization events | Factors associated with mortality during warfarin therapy |
|---|---|---|---|---|---|
Karuri et al., 2019Â [36] | CHF, renal dysfunction | NA | NA | NA | NA |
Sana et al., 2020Â [43] | CHF, and nonvalvular AF type | Hypertension and antiplatelet use | obstructive sleep apnea and higher CHA2DS2VASc score | NA | CHF, and hypertension |
Prinsloo et al., 2021 [38] | Patents aged < 50, hospitalization | NA | NA | NA | NA |
Ahmed et al., 2017 [41] | Absence of pharmacists’ intervention | NA | NA | clinical pharmacy intervention (-) | NA |
Botsile et al., 2020 [39] | NA | Duration of warfarin use, Increased level of education | NA | NA | NA |
Masresha et al., 2021 [31] | potential medication interaction, presence of co-morbid conditions | NA | NA | NA | NA |
Kizito et al., 2016Â [47] | female gender, lower education level | NA | NA | NA | NA |
Yimer et al., 2021 [40] | Receiving > 2 drugs with warfarin, heart failure comorbidity | NA | NA | NA | NA |
Rejeb et al., 2019 [29] | NA | Poor TTR (< 50%) | NA | NA | NA |
Mwita et al.,2017 [30] | Smoking and pulmonary hypertension | NA | NA | NA | NA |
Ebrahim et al., 2018 [7] | Frequent INR monitoring | NA | NA | NA | NA |